Bong Soo

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System

Sun Ok Song, Chang Hee Jung, Young Duk Song et al. · Diabetes & Metabolism Journal · 2014 · 664 citations · Full text

SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease

So Ra Kim, Sang‐Guk Lee, Soo Hyun Kim et al. · Nature Communications · 2020 · 489 citations · Full text

Immunology, Cardiovascular Pharmacology, Renal Inflammation +21

Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults

Hae Jin Kim, Hyeong Jin Kim, Kwang Eun Lee et al. · Archives of Internal Medicine · 2004 · 432 citations · Full text

Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)

Yong‐ho Lee, Seung Up Kim, Kijun Song et al. · Hepatology · 2015 · 337 citations · Full text